Anbio Biotechnology

Anbio Biotechnology

Anbio Biotechnology (Anbio) is a leading global medical device company with a focus on in vitro diagnostics. We offer cutting-edge laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions that are rapid, accessible, and affordable on a global scale.
Since its establishment, Anbio has been committed to deliver the most advanced diagnostic solutions while ensuring cost-effectiveness for our customers. Our extensive capabilities in research and development, manufacturing, and global product distribution logistics allow us to continuously focus on cost reduction while offering a wide range of mature laboratory diagnostics and point-of-care technology (POCT) products. Our product range spans across cancer, cardiovascular conditions, pharmacogenomics, hormones, infectious diseases, inflammation, and drug of abuses tests.

Contract Manufacturing, Custom Manufacturing, OEM Products, Abused Drug Testing, Alcohol Testing, Cancer Testing, Cardiac Testing, Chemistry Testing, Cholesterol Testing, Coagulation/Hemostasis, COVID, Critical Care Testing, Diabetes Testing, Drug Testing, Genetic Screening, Genetic Testing, Genomics, Glucose Testing, HbA1c Testing, Hepatitis Testing, HIV Testing, Hormones, HPV Testing, Infectious Disease Testing, Infectious Disease, Other, Influenza Testing, Laboratory Testing Services, Molecular Diagnostics, Multiplex Testing, Point of Care Testing, Pregnancy Testing, Protein Analysis, Rapid Tests, STD Testing, Thyroid Testing, Immunofluorescence, RNA Extraction, Veterinary Products, Analytical Instruments, Chemiluminescence Systems, Cancer Markers, Cardiac Markers, Pharmacogenomics, Tumor Markers